TORODEX
TORODEX, licence 80025987: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- Healthy Body Services Inc.
- NPN or DIN-HM
- 80025987
- Status
- Active licence
- Licence date
- 24 June 2011
- Revision date
- 15 March 2018
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Tribulus terrestris L.: Les parties de plantes doivent être cuites
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Serenoa repens (W.Bartram) Small: L'étiquetage doit comporter une mention recommandant de prendre conseil auprès d'un professionnel de santé ("Demander l'avis de votre médecin et /ou pharmacien").
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Acide DL-alpha lipoÏque Source : Acide DL-alpha-lipoÏque | 66.7 mg | Not calculated |
| 3,3'-Methylenebis-1H-indole Source : 3,3'-diindolylméthane | 66.67 mg | Not calculated |
| (E)-5-(p-hydroxystyryl)resorcinol Source : Resvératrol | 16.67 mg | Not calculated |
| Eurycoma longifolia Source : Racine Extraction ratio : 100:1 Dry plant equivalent : 3333 mg Potency : 22.0 % Eurypeptides | 33.33 mg | Not calculated |
| Eurycoma longifolia Source : Racine Potency : 40.0 % Glycosaponins | Not specified | Not calculated |
| Piper nigrum Source : Piper nigrum - fruit Potency : 95.0 % Piperine | 3.33 mg | Not calculated |
| Tribulus terrestris Source : Fruit | 80.0 mg | Not calculated |
| Serenoa repens Source : Fruit | 33.3 mg | Not calculated |
Non-medicinal ingredients
Gélatine, Dioxyde de titane, Stéarate de magnésium, Dioxyde de silicium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes de sexe masculin | Not specified | 3.0 Capsule | 1.0 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Source of antioxidant for the maintenance of good health.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Source
Official Health Canada record, licence 80025987
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2018. Photograph the packaging to check whether it has changed.
Has the product changed? Photograph the packaging.